Back to search

Article

Posttraumatic midazolam administration does not influence brain damage after experimental traumatic brain injury

2021-07-14

Abstract excerpt

<h4>Background: </h4> The benzodiazepine midazolam is a γ-aminobutyric acid (GABA)-A receptor agonist frequently used for sedation or stress control in patients suffering from traumatic brain injury (TBI). However, experimental studies on benzodiazepines have reported divergent results, raising concerns about its widespread use in patients. Some studies indicate that benzodiazepine-mediated potentiation of GABAerg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ef95ff2-9bfc-533b-8b1f-ea807c02e1ec
DOI
10.21203/rs.3.rs-490861/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Posttraumatic midazolam administration does not influence brain damage after experimental traumatic brain injuryDOI 10.21203/rs.3.rs-490861/v1
Select a neighboring publication to make it the new centre.